Multimodal Assessment of Immunosuppressive Therapy in a Patient With Chronic Active Myocarditis 3 Months Following COVID-19 Infection.

Multimodal Assessment of Immunosuppressive Therapy in a Patient With Chronic Active Myocarditis 3 Months Following COVID-19 Infection.

Publication date: Jun 01, 2024

Open Access PDF

Concepts Keywords
Covid Active
Immunosuppressive Assessment
Months Chronic
Open Cjc
Therapy Clinical
Covid
Immunosuppressive
Infection
Months
Multimodal
Myocarditis
Open
Patient
Therapy

Semantics

Type Source Name
disease MESH Myocarditis
disease MESH COVID-19
disease MESH Infection
disease VO viable
disease MESH chest pain
disease MESH ventricular tachycardia
drug DRUGBANK Ethambutol
disease IDO blood
disease MESH abnormalities
drug DRUGBANK Angiotensin II
drug DRUGBANK Gadolinium
disease VO volume
disease MESH edema
disease IDO cell
disease VO time
disease VO Viruses
disease MESH syndrome
drug DRUGBANK Carvedilol
drug DRUGBANK Enalapril
disease VO dose
drug DRUGBANK Dextrose unspecified form
disease MESH hypotension
disease MESH anorexia
drug DRUGBANK Prednisolone
disease VO document
disease MESH myopathy
disease MESH inflammation
disease VO effectiveness
disease IDO immunosuppression
disease MESH Cardiomyopathy
disease MESH cardiac death
disease MESH fibrosis

Original Article

(Visited 5 times, 1 visits today)